tiprankstipranks
Climb Bio (CLYM)
NASDAQ:CLYM
US Market

Climb Bio (CLYM) Similar Stocks

Compare
56 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Climb Bio
$1.47
$94.89M
-49.64%
1 Buy
0 Hold
0 Sell
Moderate Buy
SELLAS Life Sciences Group
$1.17
$93.51M
-13.97%
1 Buy
0 Hold
0 Sell
Moderate Buy
Leap Therapeutics
$0.42
$16.10M
-83.06%
1 Buy
2 Hold
0 Sell
Moderate Buy
Bioxcel Therapeutics
$2.97
$11.09M
-93.60%
2 Buy
0 Hold
1 Sell
Moderate Buy
Verrica Pharmaceuticals
$0.64
$55.06M
-87.77%
1 Buy
2 Hold
0 Sell
Moderate Buy
Foghorn Therapeutics
$4.52
$244.69M
-35.39%
5 Buy
1 Hold
0 Sell
Strong Buy
ATAI Life Sciences
$1.51
$273.53M
-30.20%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CLYM
Climb Bio
1.41
-1.39
-49.64%
SLS
SELLAS Life Sciences Group
1.17
-0.19
-13.97%
LPTX
Leap Therapeutics
0.42
-2.06
-83.06%
BTAI
Bioxcel Therapeutics
2.97
-43.43
-93.60%
VRCA
Verrica Pharmaceuticals
0.64
-4.57
-87.72%
FHTX
Foghorn Therapeutics
4.40
-2.41
-35.39%
ATAI
ATAI Life Sciences
1.41
-0.61
-30.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis